Pyrococcus furiosus Argonaute coupled with modified ligase chain reaction for detection of SARS-CoV-2 and HPV

被引:41
作者
Wang, Longyu [1 ]
He, Ruyi [1 ]
Lv, Bin [1 ]
Yu, Xiao [2 ]
Liu, Yang [1 ]
Yang, Jun [1 ]
Li, Wenqiang [1 ]
Wang, Yuan [3 ]
Zhang, Hang [1 ]
Yan, Guangbo [1 ]
Mao, Wuxiang [1 ]
Liu, Linlin [2 ]
Wang, Fei [1 ]
Ma, Lixin [1 ]
机构
[1] Hubei Univ, Hubei Collaborat Innovat Ctr Green Transformat Bi, Sch Life Sci, Hubei Key Lab Ind Biotechnol,State Key Lab Biocat, Wuhan, Hubei, Peoples R China
[2] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China
[3] Hubei Univ Arts & Sci, Med Coll, Xiangyang, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
Prokaryotic argonaute; Ligase chain reaction; SARS-CoV-2; HPV; Nucleic acid detection; NUCLEIC-ACID DETECTION; LIGATION; QUANTIFICATION; MICRORNA;
D O I
10.1016/j.talanta.2021.122154
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Infectious diseases caused by viruses such as SARS-CoV-2 and HPV have greatly endangered human health. The nucleic acid detection is essential for the early diagnosis of diseases. Here, we propose a method called PLCR (PfAgo coupled with modified Ligase Chain Reaction for nucleic acid detection) which utilizes PfAgo to only use DNA guides longer than 14-mer to specifically cleave DNA and LCR to precisely distinguish single-base mismatch. PLCR can detect DNA or RNA without PCR at attomolar sensitivities, distinguish single base mutation between the genome of wild type SARS-CoV-2 and its mutant spike D614G, effectively distinguish the novel coronavirus from other coronaviruses and finally achieve multiplexed detection in 70 min. Additionally, LCR products can be directly used as DNA guides without additional input guides to simplify primer design. With desirable sensitivity, specificity and simplicity, the method can be extended for detecting other pathogenic microorganisms.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] CRISPR-cas technology: A key approach for SARS-CoV-2 detection
    Fang, Lijuan
    Yang, Lusen
    Han, Mingyue
    Xu, Huimei
    Ding, Wenshuai
    Dong, Xuejun
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2023, 11
  • [22] iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2
    Ali, Zahir
    Aman, Rashid
    Mahas, Ahmed
    Rao, Gundra Sivakrishna
    Tehseen, Muhammad
    Marsic, Tin
    Salunke, Rahul
    Subudhi, Amit K.
    Hala, Sharif M.
    Hamdan, Samir M.
    Pain, Arnab
    Alofi, Fadwa S.
    Alsomali, Afrah
    Hashem, Anwar M.
    Khogeer, Asim
    Almontashiri, Naif A. M.
    Abedalthagafi, Malak
    Hassan, Norhan
    Mahfouz, Magdy M.
    VIRUS RESEARCH, 2020, 288
  • [23] A lab-on-a-chip for the concurrent electrochemical detection of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in saliva and plasma
    Najjar, Devora
    Rainbow, Joshua
    Timilsina, Sanjay Sharma
    Jolly, Pawan
    de Puig, Helena
    Yafia, Mohamed
    Durr, Nolan
    Sallum, Hani
    Alter, Galit
    Li, Jonathan Z.
    Yu, Xu G.
    Walt, David R.
    Paradiso, Joseph A.
    Estrela, Pedro
    Collins, James J.
    Ingber, Donald E.
    NATURE BIOMEDICAL ENGINEERING, 2022, 6 (08) : 968 - +
  • [24] Emerging Landscape of SARS-CoV-2 Variants and Detection Technologies
    Li, Xianghui
    Wang, Jing
    Geng, Jingping
    Xiao, Liming
    Wang, Hu
    MOLECULAR DIAGNOSIS & THERAPY, 2023, 27 (02) : 159 - 177
  • [25] CDetection.v2: One-pot assay for the detection of SARS-CoV-2
    Wang, Xinge
    Chen, Yangcan
    Cheng, Xuejia
    Wang, Si-Qi
    Hu, Yanping
    Feng, Yingmei
    Jin, Ronghua
    Zhou, Kangping
    Liu, Ti
    Wang, Jianxing
    Pan, Kai
    Liu, Bing
    Xiang, Jie
    Wang, Yanping
    Zhou, Qi
    Zhang, Ying
    Pan, Weiye
    Li, Wei
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [26] Laboratory Management and Quality Control Practice of SARS-CoV-2 Nucleic Acid Detection
    Xiao, Shiwei
    Yue, Junqiu
    Zhang, Tianming
    Wang, Mingwei
    Jin, Su
    Zhang, Junfei
    Zhang, Sheng
    Xu, Pengfei
    Wu, De
    Hu, Jianhua
    Guo, Fang
    LABORATORY MEDICINE, 2021, 52 (01) : E8 - E14
  • [27] Molecular detection of SARS-CoV-2 being challenged by virus variation and asymptomatic infection
    Jiang, Congshan
    Li, Xiaowei
    Ge, Changrong
    Ding, Yuanyuan
    Zhang, Tao
    Cao, Shuai
    Meng, Liesu
    Lu, Shemin
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2021, 11 (03) : 257 - 264
  • [28] Nanozyme-strip for rapid and ultrasensitive nucleic acid detection of SARS-CoV-2
    Meng, Xiangqin
    Zou, Sijia
    Li, Dandan
    He, Jiuyang
    Fang, Ling
    Wang, Haojue
    Yan, Xiyun
    Duan, Demin
    Gao, Lizeng
    BIOSENSORS & BIOELECTRONICS, 2022, 217
  • [29] Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2
    Arizti-Sanz, Jon
    Freije, Catherine A.
    Stanton, Alexandra C.
    Petros, Brittany A.
    Boehm, Chloe K.
    Siddiqui, Sameed
    Shaw, Bennett M.
    Adams, Gordon
    Kosoko-Thoroddsen, Tinna-Solveig F.
    Kemball, Molly E.
    Uwanibe, Jessica N.
    Ajogbasile, Fehintola V.
    Eromon, Philomena E.
    Gross, Robin
    Wronka, Loni
    Caviness, Katie
    Hensley, Lisa E.
    Bergman, Nicholas H.
    MacInnis, Bronwyn L.
    Happi, Christian T.
    Lemieux, Jacob E.
    Sabeti, Pardis C.
    Myhrvold, Cameron
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [30] CRISPR-based detection of SARS-CoV-2: A review from sample to result
    Nouri, Reza
    Tang, Zifan
    Dong, Ming
    Liu, Tianyi
    Kshirsagar, Aneesh
    Guan, Weihua
    BIOSENSORS & BIOELECTRONICS, 2021, 178